Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
Quantitative Time-of-Flight Head Magnetic Resonance Angiography of Cerebrovascular Disease.
A pilot study of clonidine plus physostigmine in Alzheimer's disease.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A pilot study of clonidine plus physostigmine in Alzheimer's disease.
A pilot study of clonidine plus physostigmine in Alzheimer's disease. Dementia. 1994 Sep-Oct; 5(5):243-6.
View in:
PubMed
subject areas
Aged
Alzheimer Disease
Clonidine
Cognition
Drug Therapy, Combination
Female
Humans
Male
Methoxyhydroxyphenylglycol
Middle Aged
Norepinephrine
Physostigmine
Pilot Projects
authors with profiles
Michael Davidson